nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylscopolamine bromide—CHRM2—forebrain—attention deficit hyperactivity disorder	0.00831	0.095	CbGeAlD
Methylscopolamine bromide—CHRM1—forebrain—attention deficit hyperactivity disorder	0.00757	0.0864	CbGeAlD
Methylscopolamine bromide—CHRM2—cardiovascular system—attention deficit hyperactivity disorder	0.00703	0.0803	CbGeAlD
Methylscopolamine bromide—CHRM3—forebrain—attention deficit hyperactivity disorder	0.00677	0.0774	CbGeAlD
Methylscopolamine bromide—CHRM5—nervous system—attention deficit hyperactivity disorder	0.00657	0.0751	CbGeAlD
Methylscopolamine bromide—CHRM1—cardiovascular system—attention deficit hyperactivity disorder	0.0064	0.0731	CbGeAlD
Methylscopolamine bromide—CHRM5—central nervous system—attention deficit hyperactivity disorder	0.00633	0.0723	CbGeAlD
Methylscopolamine bromide—CHRM5—brain—attention deficit hyperactivity disorder	0.00502	0.0574	CbGeAlD
Methylscopolamine bromide—CHRM2—nervous system—attention deficit hyperactivity disorder	0.00451	0.0516	CbGeAlD
Methylscopolamine bromide—CHRM2—central nervous system—attention deficit hyperactivity disorder	0.00434	0.0496	CbGeAlD
Methylscopolamine bromide—CHRM1—nervous system—attention deficit hyperactivity disorder	0.00411	0.0469	CbGeAlD
Methylscopolamine bromide—CHRM1—central nervous system—attention deficit hyperactivity disorder	0.00395	0.0452	CbGeAlD
Methylscopolamine bromide—CHRM3—nervous system—attention deficit hyperactivity disorder	0.00368	0.042	CbGeAlD
Methylscopolamine bromide—CHRM3—central nervous system—attention deficit hyperactivity disorder	0.00354	0.0404	CbGeAlD
Methylscopolamine bromide—CHRM2—brain—attention deficit hyperactivity disorder	0.00345	0.0394	CbGeAlD
Methylscopolamine bromide—CHRM1—brain—attention deficit hyperactivity disorder	0.00314	0.0359	CbGeAlD
Methylscopolamine bromide—CHRM3—brain—attention deficit hyperactivity disorder	0.00281	0.0321	CbGeAlD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00145	0.00159	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00145	0.00159	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00145	0.00158	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00143	0.00157	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.00141	0.00154	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00136	0.00149	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00136	0.00149	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.00136	0.00149	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.00136	0.00149	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00135	0.00148	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00135	0.00147	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00134	0.00146	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00133	0.00146	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00132	0.00145	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—DRD3—attention deficit hyperactivity disorder	0.00131	0.00143	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—ADRA2A—attention deficit hyperactivity disorder	0.00128	0.00141	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00128	0.0014	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—DRD4—attention deficit hyperactivity disorder	0.00127	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00127	0.00139	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00126	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00126	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00126	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00126	0.00138	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00125	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00125	0.00137	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00123	0.00135	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00122	0.00134	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00121	0.00133	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00121	0.00132	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0012	0.00132	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.0012	0.00132	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00119	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00119	0.00131	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00119	0.0013	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—G alpha (i) signalling events—DRD2—attention deficit hyperactivity disorder	0.00118	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00118	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00118	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00117	0.00129	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00117	0.00128	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00116	0.00128	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00115	0.00126	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00115	0.00126	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00115	0.00126	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00114	0.00125	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00114	0.00125	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00113	0.00124	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00112	0.00123	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00111	0.00122	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00111	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.0011	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.0011	0.00121	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.0011	0.0012	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00109	0.0012	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00109	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00108	0.00119	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00107	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00107	0.00117	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00105	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00105	0.00115	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00104	0.00114	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00103	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00103	0.00113	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00102	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00102	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00102	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00102	0.00112	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00101	0.00111	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00101	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00101	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.001	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.001	0.0011	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000962	0.00105	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000951	0.00104	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000948	0.00104	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000946	0.00104	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.000939	0.00103	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.0009	0.000986	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.000897	0.000983	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000889	0.000975	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000887	0.000972	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.000878	0.000962	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000847	0.000928	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000844	0.000925	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.000836	0.000916	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00083	0.000909	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000827	0.000906	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000827	0.000906	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000824	0.000903	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.000819	0.000897	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000817	0.000895	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.000816	0.000895	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000801	0.000878	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000798	0.000875	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.000791	0.000866	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000787	0.000863	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000785	0.00086	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000777	0.000852	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000777	0.000852	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.000777	0.000852	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000775	0.000849	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000775	0.000849	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000769	0.000843	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.000767	0.000841	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.000767	0.000841	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000767	0.00084	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.000759	0.000832	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000753	0.000826	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000751	0.000823	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000751	0.000823	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.000744	0.000815	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000742	0.000813	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000724	0.000794	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000722	0.000791	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00072	0.000789	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.000715	0.000783	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000714	0.000782	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000677	0.000742	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000675	0.00074	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.000669	0.000733	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000666	0.00073	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000664	0.000728	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000664	0.000727	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.000658	0.000721	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000648	0.00071	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000645	0.000707	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000643	0.000704	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000632	0.000693	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000632	0.000692	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000624	0.000684	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.00062	0.000679	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000608	0.000666	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000603	0.00066	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000584	0.00064	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000581	0.000637	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000575	0.00063	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000574	0.000629	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000573	0.000628	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.000568	0.000622	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000567	0.000621	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ADRA2C—attention deficit hyperactivity disorder	0.000542	0.000593	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000529	0.000579	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000528	0.000578	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000527	0.000578	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000522	0.000572	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.000522	0.000572	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000521	0.00057	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.000515	0.000565	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000507	0.000556	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000506	0.000554	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000503	0.000551	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000503	0.000551	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000501	0.000549	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.000501	0.000549	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.000496	0.000544	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000467	0.000512	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000466	0.00051	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.000461	0.000506	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000456	0.0005	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000455	0.000499	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000454	0.000498	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000453	0.000496	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000453	0.000496	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000451	0.000494	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.000451	0.000494	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.000448	0.000491	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.000447	0.00049	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000445	0.000488	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000445	0.000487	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000444	0.000486	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000443	0.000486	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000439	0.000481	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.000439	0.000481	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.000439	0.000481	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000438	0.00048	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000438	0.00048	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000436	0.000478	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000435	0.000477	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.000434	0.000475	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.000431	0.000472	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000424	0.000465	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000423	0.000464	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.000419	0.000459	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000411	0.00045	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.00041	0.000449	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000409	0.000449	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000408	0.000447	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000407	0.000446	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.000406	0.000445	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.000404	0.000443	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000404	0.000443	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000403	0.000441	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000399	0.000437	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.000399	0.000437	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000398	0.000436	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.000394	0.000432	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000383	0.00042	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—TPH2—attention deficit hyperactivity disorder	0.000374	0.00041	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CACNB2—attention deficit hyperactivity disorder	0.000374	0.00041	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000372	0.000407	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00037	0.000406	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00037	0.000405	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—DPYD—attention deficit hyperactivity disorder	0.000368	0.000403	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.000367	0.000402	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000356	0.00039	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000345	0.000378	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—CACNA1C—attention deficit hyperactivity disorder	0.000342	0.000375	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000339	0.000371	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000335	0.000367	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000312	0.000342	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000308	0.000338	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000307	0.000337	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.000305	0.000334	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—SNAP25—attention deficit hyperactivity disorder	0.000299	0.000327	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000287	0.000314	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000286	0.000313	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—ADRA2A—attention deficit hyperactivity disorder	0.000284	0.000312	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.000283	0.00031	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.00027	0.000295	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000269	0.000295	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000266	0.000292	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.00026	0.000285	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000259	0.000284	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000257	0.000282	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000251	0.000275	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.00025	0.000274	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000247	0.000271	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000243	0.000266	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000242	0.000265	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.00024	0.000263	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000239	0.000262	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000238	0.000261	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000236	0.000258	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000236	0.000258	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000235	0.000257	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000233	0.000255	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—COMT—attention deficit hyperactivity disorder	0.000226	0.000248	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—MAOA—attention deficit hyperactivity disorder	0.000225	0.000246	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.00022	0.000241	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000219	0.00024	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000218	0.000239	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000217	0.000238	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000154	0.000169	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000153	0.000168	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000152	0.000166	CbGpPWpGaD
Methylscopolamine bromide—CHRM5—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000116	0.000127	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Metabolism—EP300—attention deficit hyperactivity disorder	9.71e-05	0.000106	CbGpPWpGaD
Methylscopolamine bromide—CHRM1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.15e-05	8.93e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM3—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.12e-05	8.9e-05	CbGpPWpGaD
Methylscopolamine bromide—CHRM2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	8.04e-05	8.81e-05	CbGpPWpGaD
